Matinas BioPharma Holdings Inc (MTNB)
0.6404
-0.07
(-9.80%)
USD |
NYAM |
Nov 14, 16:00
0.6404
0.00 (0.00%)
After-Hours: 17:19
Matinas BioPharma Holdings Enterprise Value: -10.75M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -10.75M |
| November 12, 2024 | -10.57M |
| November 11, 2024 | -9.798M |
| November 08, 2024 | -10.82M |
| November 07, 2024 | -11.53M |
| November 06, 2024 | -11.65M |
| November 05, 2024 | -11.55M |
| November 04, 2024 | -11.47M |
| November 01, 2024 | -11.39M |
| October 31, 2024 | -11.20M |
| October 30, 2024 | -4.632M |
| October 29, 2024 | -0.3175M |
| October 28, 2024 | 1.739M |
| October 25, 2024 | 1.99M |
| October 24, 2024 | 1.789M |
| October 23, 2024 | 2.542M |
| October 22, 2024 | 4.348M |
| October 21, 2024 | 4.398M |
| October 18, 2024 | 6.354M |
| October 17, 2024 | 6.154M |
| October 16, 2024 | 5.200M |
| October 15, 2024 | 3.144M |
| October 14, 2024 | 1.589M |
| October 11, 2024 | 1.639M |
| October 10, 2024 | 1.789M |
| Date | Value |
|---|---|
| October 09, 2024 | 1.594M |
| October 08, 2024 | 2.191M |
| October 07, 2024 | 1.890M |
| October 04, 2024 | 0.761M |
| October 03, 2024 | 0.4851M |
| October 02, 2024 | 1.087M |
| October 01, 2024 | 2.793M |
| September 30, 2024 | 3.445M |
| September 27, 2024 | 3.595M |
| September 26, 2024 | 3.595M |
| September 25, 2024 | 3.946M |
| September 24, 2024 | 3.645M |
| September 23, 2024 | 4.147M |
| September 20, 2024 | 4.197M |
| September 19, 2024 | 4.598M |
| September 18, 2024 | 3.344M |
| September 17, 2024 | 3.706M |
| September 16, 2024 | 4.298M |
| September 13, 2024 | 4.950M |
| September 12, 2024 | 4.097M |
| September 11, 2024 | 3.420M |
| September 10, 2024 | 3.746M |
| September 09, 2024 | 2.893M |
| September 06, 2024 | 2.993M |
| September 05, 2024 | 3.946M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.65M
Minimum
Nov 06 2024
353.10M
Maximum
Jan 02 2020
101.92M
Average
99.42M
Median
Jan 26 2023
Enterprise Value Benchmarks
| Equillium Inc | -5.654M |
| Tenon Medical Inc | 2.957M |
| Alphatec Holdings Inc | 1.741B |
| Merck & Co Inc | 272.77B |
| Madrigal Pharmaceuticals Inc | 5.992B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.719M |
| Total Expenses (Quarterly) | 5.839M |
| EPS Diluted (Quarterly) | -1.00 |
| Earnings Yield | -858.8% |
| Normalized Earnings Yield | -922.09 |